These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 30429088)
1. SRSF1 modulates PTPMT1 alternative splicing to regulate lung cancer cell radioresistance. Sheng J; Zhao Q; Zhao J; Zhang W; Sun Y; Qin P; Lv Y; Bai L; Yang Q; Chen L; Qi Y; Zhang G; Zhang L; Gu C; Deng X; Liu H; Meng S; Gu H; Liu Q; Coulson JM; Li X; Sun B; Wang Y EBioMedicine; 2018 Dec; 38():113-126. PubMed ID: 30429088 [TBL] [Abstract][Full Text] [Related]
2. Splicing factor SRSF1 promotes breast cancer progression via oncogenic splice switching of PTPMT1. Du JX; Luo YH; Zhang SJ; Wang B; Chen C; Zhu GQ; Zhu P; Cai CZ; Wan JL; Cai JL; Chen SP; Dai Z; Zhu W J Exp Clin Cancer Res; 2021 May; 40(1):171. PubMed ID: 33992102 [TBL] [Abstract][Full Text] [Related]
3. SRSF1 inhibits autophagy through regulating Bcl-x splicing and interacting with PIK3C3 in lung cancer. Lv Y; Zhang W; Zhao J; Sun B; Qi Y; Ji H; Chen C; Zhang J; Sheng J; Wang T; Dominguez D; Liu H; Liu Q; Meng S; Li X; Wang Y Signal Transduct Target Ther; 2021 Mar; 6(1):108. PubMed ID: 33664238 [TBL] [Abstract][Full Text] [Related]
4. AMP-activated protein kinase regulates alternative pre-mRNA splicing by phosphorylation of SRSF1. Matsumoto E; Akiyama K; Saito T; Matsumoto Y; Kobayashi KI; Inoue J; Yamamoto Y; Suzuki T Biochem J; 2020 Jun; 477(12):2237-2248. PubMed ID: 32453427 [TBL] [Abstract][Full Text] [Related]
5. High expression of SRSF1 facilitates osteosarcoma progression and unveils its potential mechanisms. Li S; Huang X; Zheng S; Zhang W; Liu F; Cao Q BMC Cancer; 2024 May; 24(1):580. PubMed ID: 38735973 [TBL] [Abstract][Full Text] [Related]
6. Altered VEGF Splicing Isoform Balance in Tumor Endothelium Involves Activation of Splicing Factors Srpk1 and Srsf1 by the Wilms' Tumor Suppressor Wt1. Wagner KD; El Maï M; Ladomery M; Belali T; Leccia N; Michiels JF; Wagner N Cells; 2019 Jan; 8(1):. PubMed ID: 30641926 [TBL] [Abstract][Full Text] [Related]
7. Splicing factor SRSF1 promotes gliomagenesis via oncogenic splice-switching of MYO1B. Zhou X; Wang R; Li X; Yu L; Hua D; Sun C; Shi C; Luo W; Rao C; Jiang Z; Feng Y; Wang Q; Yu S J Clin Invest; 2019 Feb; 129(2):676-693. PubMed ID: 30481162 [TBL] [Abstract][Full Text] [Related]
8. Isoform Switching Regulates the Response to Ionizing Radiation Through SRSF1. Abdulghani M; Razavian NB; Burdick JT; Domingo E; Cheung VG; Humphrey TC Int J Radiat Oncol Biol Phys; 2024 Aug; 119(5):1517-1529. PubMed ID: 38447610 [TBL] [Abstract][Full Text] [Related]
9. SRSF1 and RBM4 differentially modulate the oncogenic effect of HIF-1α in lung cancer cells through alternative splicing mechanism. Chang HL; Lin JC Biochim Biophys Acta Mol Cell Res; 2019 Dec; 1866(12):118550. PubMed ID: 31491447 [TBL] [Abstract][Full Text] [Related]
10. CircSMARCA5 Inhibits Migration of Glioblastoma Multiforme Cells by Regulating a Molecular Axis Involving Splicing Factors SRSF1/SRSF3/PTB. Barbagallo D; Caponnetto A; Cirnigliaro M; Brex D; Barbagallo C; D'Angeli F; Morrone A; Caltabiano R; Barbagallo GM; Ragusa M; Di Pietro C; Hansen TB; Purrello M Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29415469 [TBL] [Abstract][Full Text] [Related]
11. SRSF1-dependent alternative splicing attenuates BIN1 expression in non-small cell lung cancer. Wang J; Liu T; Wang M; Lv W; Wang Y; Jia Y; Zhang R; Liu L J Cell Biochem; 2020 Feb; 121(2):946-953. PubMed ID: 31478261 [TBL] [Abstract][Full Text] [Related]
12. SRPK1/2 and PP1α exert opposite functions by modulating SRSF1-guided MKNK2 alternative splicing in colon adenocarcinoma. Liu H; Gong Z; Li K; Zhang Q; Xu Z; Xu Y J Exp Clin Cancer Res; 2021 Feb; 40(1):75. PubMed ID: 33602301 [TBL] [Abstract][Full Text] [Related]
13. Oncogenic splicing factor SRSF1 is a critical transcriptional target of MYC. Das S; Anczuków O; Akerman M; Krainer AR Cell Rep; 2012 Feb; 1(2):110-7. PubMed ID: 22545246 [TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA DGCR5 involves in tumorigenesis of esophageal squamous cell carcinoma via SRSF1-mediated alternative splicing of Mcl-1. Duan Y; Jia Y; Wang J; Liu T; Cheng Z; Sang M; Lv W; Qin J; Liu L Cell Death Dis; 2021 Jun; 12(6):587. PubMed ID: 34099633 [TBL] [Abstract][Full Text] [Related]
15. SRSF1 Prevents DNA Damage and Promotes Tumorigenesis through Regulation of DBF4B Pre-mRNA Splicing. Chen L; Luo C; Shen L; Liu Y; Wang Q; Zhang C; Guo R; Zhang Y; Xie Z; Wei N; Wu W; Han J; Feng Y Cell Rep; 2017 Dec; 21(12):3406-3413. PubMed ID: 29262322 [TBL] [Abstract][Full Text] [Related]
16. Cyclin K interacts with β-catenin to induce Cyclin D1 expression and facilitates tumorigenesis and radioresistance in lung cancer. Yao G; Tang J; Yang X; Zhao Y; Zhou R; Meng R; Zhang S; Dong X; Zhang T; Yang K; Wu G; Xu S Theranostics; 2020; 10(24):11144-11158. PubMed ID: 33042275 [No Abstract] [Full Text] [Related]
17. Identification of alternative splicing events regulated by the oncogenic factor SRSF1 in lung cancer. de Miguel FJ; Sharma RD; Pajares MJ; Montuenga LM; Rubio A; Pio R Cancer Res; 2014 Feb; 74(4):1105-15. PubMed ID: 24371231 [TBL] [Abstract][Full Text] [Related]
18. SRSF1-Regulated Alternative Splicing in Breast Cancer. Anczuków O; Akerman M; Cléry A; Wu J; Shen C; Shirole NH; Raimer A; Sun S; Jensen MA; Hua Y; Allain FH; Krainer AR Mol Cell; 2015 Oct; 60(1):105-17. PubMed ID: 26431027 [TBL] [Abstract][Full Text] [Related]
19. Dysregulation of alternative splicing contributes to multiple myeloma pathogenesis. Song S; Zhang W; Li Q; Wang Z; Su Q; Zhang X; Li B; Zhuang W Br J Cancer; 2023 Apr; 128(6):1086-1094. PubMed ID: 36593359 [TBL] [Abstract][Full Text] [Related]
20. Circ_000829 Plays an Anticancer Role in Renal Cell Carcinoma by Suppressing SRSF1-Mediated Alternative Splicing of SLC39A14. Feng JF; Yang WY; Wang YD; Xie G; Xu B; Dai CM; Zhang B; Li XH; Wang J; Yang YW Oxid Med Cell Longev; 2022; 2022():8645830. PubMed ID: 36062189 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]